Filing Details

Accession Number:
0001293301-13-000006
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-11 14:59:08
Reporting Period:
2013-03-07
Filing Date:
2013-03-11
Accepted Time:
2013-03-11 14:59:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
38074 Forest Laboratories Inc FRX Pharmaceutical Preparations (2834) 111798614
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1361580 Nesli Basgoz C/O Forest Laboratories, Inc.
909 Third Avenue
New York NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-03-07 4,000 $26.25 13,074 No 4 M Direct
Common Stock Acquisiton 2013-03-07 5,621 $28.23 18,695 No 4 M Direct
Common Stock Disposition 2013-03-07 212 $37.44 18,483 No 4 S Direct
Common Stock Disposition 2013-03-07 6,321 $37.44 12,162 No 4 S Direct
Common Stock Disposition 2013-03-07 1,663 $37.45 10,499 No 4 S Direct
Common Stock Disposition 2013-03-07 1,425 $37.46 9,074 No 4 S Direct
Common Stock Disposition 2013-03-07 197 $37.49 8,877 No 4 S Direct
Common Stock Disposition 2013-03-07 1,979 $37.49 6,898 No 4 S Direct
Common Stock Disposition 2013-03-07 403 $37.50 6,495 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-03-07 4,000 $0.00 4,000 $26.25
Common Stock Stock Option (Right to Buy) Disposition 2013-03-07 5,621 $0.00 5,621 $28.23
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-02-10 2019-08-09 No 4 M Direct
0 2011-02-09 2020-08-08 No 4 M Direct
Footnotes
  1. This amount includes shares of common stock which are subject to a risk of forfeiture.
  2. Not Applicable.